Trademarkia Logo

Canada

C$
Trademark Search in Canada
CASEBIA & DESIGN (VERTICAL)

View On IC.GC.CA

CASEBIA & DESIGN (VERTICAL)
REGISTERED

on 25 Jul 2019

Last Applicant/ Owned by

CASEBIA THERAPEUTICS LIMITED LIABILITY PARTNERSHIP

c/o Taylor Wessing LLP5 New Street SquareLondon EC4A3TW

GB

Serial Number

1790207 filed on 6th Jul 2016

Registration Number

TMA1044701 registered on 25th Jul 2019

Registration expiry Date

25th Jul 2029

Correspondent Address

BORDEN LADNER GERVAIS LLP

ATTN: INTELLECTUAL PROPERTY DEPARTMENT1000 DE LA GAUCHETIERE STREET WESTSUITE 900MONTREAL

QUEBEC

CA

H3B5H4

CASEBIA & DESIGN (VERTICAL)

Trademark usage description

gene therapy products, namely, therapeutic preparations for the treatment of hepatological, namely, liver, gallbladder, and pancreas diseases and diso Read More

Vienna Information

26 . 7 . 5

Circles or ellipses with one or more other quadrilateralsCercles ou ellipses avec un ou plusieurs quadrilatères

26 . 7 . 7

Circle or ellipses with one or more other polygonsCercles ou ellipses avec un ou plusieurs autres polygones

26 . 4 . 1

SquaresCarrés

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 5 . 1

One polygonUn polygone

Classification Information

Class [005]
Gene therapy products, namely, therapeutic preparations for the treatment of hepatological, namely, liver, gallbladder, and pancreas diseases and disorders, cardiovascular, central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases, endocrine, gastrointestinal, immunological, namely, autoimmune diseases and immunologic deficiency syndromes, dermatological, namely, dermatitis, skin pigmentation diseases, eczema and psoriaris, infectious, namely respiratory infections, eye infections and topical infections, inflammatory, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, menopausal, metabolic, namely, diabetes, hypoglycaemia, gout and anorexia, autoimmune, musculoskeletal, neurological, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease and cerebral palsy, ophthalmologic, psychiatric, namely, mood disorders, anxiety disorders, cognitive disorders and schizophrenia, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders, namely, herpes and hepatitis

Classification kind code

10

Class [042]
Research and development of human therapeutics using gene editing; pharmaceutical research and development services

Classification kind code

10

Mark Details

Serial Number

1790207

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 50
on 26th Jan 2018		Allowed
Submitted for opposition 51
on 26th Jan 2018		Allowance Notice Sent
Submitted for opposition 42
on 11th Oct 2017		Advertised
Submitted for opposition 26
on 21st Sept 2017		Approved
Submitted for opposition 27
on 4th Aug 2017		Approval Notice Sent
Submitted for opposition 22
on 19th Jan 2017		Search Recorded
Submitted for opposition 20
on 19th Jan 2017		Examiner's First Report
Submitted for opposition 31
on 12th Jul 2016		Formalized
Submitted for opposition 1
on 7th Jul 2016		Created
Submitted for opposition 30
on 6th Jul 2016		Filed